161 related articles for article (PubMed ID: 21808950)
1. Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome.
Yiu CR; Kao YH; Phipps C; Tan D
Singapore Med J; 2011 Jul; 52(7):e156-9. PubMed ID: 21808950
[TBL] [Abstract][Full Text] [Related]
2. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
3. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma.
Harada S; Shinohara T; Naruse K; Machida H
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796
[No Abstract] [Full Text] [Related]
4. Utility of fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin diagnosed as lymphoma.
Sheng ZK; Ye J; Li JJ; Zhao K; Sheng JF
Med Princ Pract; 2014; 23(5):437-42. PubMed ID: 25034855
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
6. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
7. Significant contribution of Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in a case of acute lymphoblastic leukemia presenting with fever of unknown origin.
Arslan F; Yilmaz M; Cakir T; Mert A
Intern Med; 2014; 53(7):789-91. PubMed ID: 24694498
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis.
Yuan L; Kan Y; Meeks JK; Ma D; Yang J
Diagn Interv Radiol; 2016; 22(5):471-5. PubMed ID: 27537853
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Mimicking Lymphoma on FDG PET/CT.
Pan Q; Luo Y; Wu H; Ma Y; Li F
Clin Nucl Med; 2018 Feb; 43(2):125-127. PubMed ID: 29215415
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma.
Pinilla I; Gómez-León N; Del Campo-Del Val L; Hernandez-Maraver D; Rodríguez-Vigil B; Jover-Díaz R; Coya J
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):567-75. PubMed ID: 21150860
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
13. [Sarcoidosis-lymphoma syndrome].
Partanen A; Pukkila S; Jantunen E
Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
[TBL] [Abstract][Full Text] [Related]
14. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of F-18 FDG PET/CT in patients with secondary hemophagocytic syndrome].
Wang XB; Zhu YX; Liu X; Pan B; Zhang L; Han YS; Cai XY; Zhu WB; Wu JS; Sun ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1698-701. PubMed ID: 25543499
[TBL] [Abstract][Full Text] [Related]
16. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT findings of peritoneal lymphomatosis.
Kaneko K; Masunari S; Yoshida T; Omagari J
Clin Nucl Med; 2012 Nov; 37(11):1117-9. PubMed ID: 22996239
[TBL] [Abstract][Full Text] [Related]
18. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.
Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ
Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788
[TBL] [Abstract][Full Text] [Related]
19. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission.
Corapcioglu F; Oncel S; Berberoğlu K; Klç SC; Aydoğan A; Doğan S
J Pediatr Hematol Oncol; 2009 Jan; 31(1):74-5. PubMed ID: 19125095
[No Abstract] [Full Text] [Related]
20. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
